"CHANGE COVID-19 Severity"

Summary

"CHANGE COVID-19 Severity" is a clinical trial^[1].

Key Facts

• "CHANGE COVID-19 Severity" is in the country of United States^[2].
• "CHANGE COVID-19 Severity"'s instance of is recorded as clinical trial^[3].
• "CHANGE COVID-19 Severity"'s start time is recorded as +2021-06-25T00:00:00Z^[4].
• "CHANGE COVID-19 Severity"'s end time is recorded as +2023-06-25T00:00:00Z^[5].
• "CHANGE COVID-19 Severity"'s number of participants is recorded as {'unit': '1', 'amount': '+30'}^[6].
• "CHANGE COVID-19 Severity"'s title is recorded as Investigation of Choice Alteration of the Gut Metagenome on COVID-19 Severity^[7].
• "CHANGE COVID-19 Severity"'s short name is recorded as CHANGE^[8].
• "CHANGE COVID-19 Severity"'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[9].
• "CHANGE COVID-19 Severity"'s ClinicalTrials.gov ID is recorded as NCT04941703^[10].
• "CHANGE COVID-19 Severity"'s maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+99'}^[11].
• "CHANGE COVID-19 Severity"'s research intervention is recorded as magnesium citrate^[12].
• "CHANGE COVID-19 Severity"'s clinical trial phase is recorded as phase I clinical trial^[13].
• "CHANGE COVID-19 Severity"'s clinical trial phase is recorded as phase II clinical trial^[14].
• "CHANGE COVID-19 Severity"'s research site is recorded as Vanderbilt University Medical Center^[15].
• "CHANGE COVID-19 Severity"'s research subject recruitment status is recorded as recruiting^[16].
• "CHANGE COVID-19 Severity"'s study type is recorded as interventional study^[17].